ClinTech Research India Pvt Ltd is a wholly owned subsidiary of ClinTech Research LLC, a New Jersey, USA based Contract Research Organization. The company provides Preclinical Toxicology & Pharmacology services, and Clinical Trials Monitoring & Regulatory Support in India, to Pharmaceuticals, Biotechnology and Nutraceutical companies. ClinTech Research founded in 2005 is led by professional CEO; Dr. Sri Prakash Srivastava who has more than 20 years of experience in drug development within the US industry. ClinTech Research provides Preclinical Toxicology & Pharmacology services through a network of partners that include internationally recognized research institutions and GLP-accredited CROs in India & in the USA. The company offers both GLP compliant regulatory toxicology studies for Investigational New Drug (IND) submission as well as non-GLP toxicology and pharmacology studies in order to provide preliminary assessment of a drug's safety and efficacy. It also offers Clinical Monitoring & Regulatory Support Services in India, as part of the global clinical Trial registration, to pharmaceutical, biotechnology, Nutraceutical companies and to the CROs for a broad range of therapeutic areas including Oncology, Psychiatry & Diabetes. It offers interactive ‘Online courses’ and ‘Hands-On Workshop training’ in Clinical Research with an aim to develop human resources in the growing field of Clinical Research in India. ClinTech Research is well positioned to assist pharmaceutical, biotechnology companies in their effort to develop novel drugs to meet an unmet medical need in a cost-effective manner. The company has set up its basic infrastructure and network of partners in India and in the USA. In next 2-3 years, ClinTech Research is planning to accelerate its infrastructure investment by establishing research laboratory to compliment existing partners’ capabilities to meet global outsourcing demands. The company is planning to approximately double its manpower to 14-16 in 2009-10, and projecting to approach 25-30 during 2010-11. At present the company has leased out 300 sq ft. space on first floor of Bio-business block for its office in Biotech Park.
|
|